Selective androgen receptor modulator has anti-tumor effects in ER-positive breast cancer patients

A research paper published today (8 February 2024) in The Lancet Oncology demonstrates that the drug enobosarm, a selective androgen receptor modulator which stimulates the male sex hormone receptor has anti-tumour effects in estrogen receptor positive breast cancer patients.

New analysis reveals postpartum sterilization rates are higher among U.S. women with sickle cell

You’re reading Part 4 of Coercive Care, a yearlong examination of the denial of reproductive autonomy for people with sickle cell disease. Often, women with

October 2, 2024

How the twin crises of climate change and poor public housing are harming people’s health

Climate change is an existential problem for human health. As climate change intensifies, the frequency and severity of extreme weather events such as heatwaves, cold

August 29, 2023

Key Senate panel to consider PBM, drug pricing reform package

WASHINGTON — A key Senate panel announced it will consider more policies to regulate pharmacy middlemen and ensure patients aren’t paying more than insurers do

November 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.